Intrinsic Value of S&P & Nasdaq Contact Us

CorMedix Inc. CRMD

NASDAQ Global Market

SharesGrow Score
82/100
5/7 Pass
SharesGrow Intrinsic Value
$31.96
+337.8%
Analyst Price Target
$13.75
+88.4%

CorMedix Inc. (CRMD) current share price is $7.30. The gold spot price is $4,825.20 per troy ounce. Using the formula: CRMD in gold = $7.30 × 31.1035 ÷ $4,825.20 = 0.0471 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of CRMD when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding CRMD shares over the measured period.

CRMD in US Dollars
Gold in US Dollars
CRMD in Gold (grams per share)

Real Wealth Growth Rate

CRMD
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{CRMD}_{\text{gold}}(t) = \frac{P_{\text{CRMD}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{CRMD}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{CRMD}_{\text{gold}}^{(T)}}{\text{CRMD}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{CRMD}_\text{gold}^{(0)}$ = initial gold-price, $\text{CRMD}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

CELC
CELC
Celcuity Inc.
$120.85
+0.37%
TVTX
TVTX
Travere Therapeutics, Inc.
$42.13
+37.23%
TARS
TARS
Tarsus Pharmaceuticals, Inc.
$73.81
+1.60%
ELVN
ELVN
Enliven Therapeutics, Inc.
$44.85
+2.33%
NUVB
NUVB
Nuvation Bio Inc.
$4.85
+3.19%
INBX
INBX
Inhibrx Biosciences, Inc.
$83.19
+7.40%
PGEN
PGEN
Precigen, Inc.
$3.96
-5.04%
ETON
ETON
Eton Pharmaceuticals, Inc.
$27.12
+4.11%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message